San Diego, CA, United States of America

Bradley Hayes

USPTO Granted Patents = 1 


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: An Insight into Inventor Bradley Hayes from San Diego, CA

Introduction

Bradley Hayes, an innovative inventor based in San Diego, California, has made significant contributions to the field of biotechnology. With one patent to his name, he showcases the fusion of creativity and scientific research to enhance the efficiency of antibody conjugation processes.

Latest Patents

Bradley Hayes holds a patent for an invention titled "Preparing antibodies from CHO cell cultures for conjugation." This invention is pivotal as it addresses the challenges posed by a CHO cell oxidizing enzyme, particularly QSOX1, which can affect the efficiency of antibody purification and subsequent conjugation. The invention presents a method that recognizes the dependence of the oxidizing enzyme's survival on the purification techniques employed, which can vary for different antibodies. By mechanizing a purification scheme that effectively eliminates or reduces CHO oxidizing enzymes, Hayes' work ensures a more reliable process for antibody-drug conjugation.

Career Highlights

Currently affiliated with Seattle Genetics, Inc., Bradley Hayes has positioned himself at the forefront of biopharmaceutical innovation. His expertise and contributions have been instrumental in driving advancements in antibody-based therapies, making him a valuable asset to his organization and the industry at large.

Collaborations

Bradley works alongside talented coworkers, including Kevin Beam and Damon L Meyer. Together, they collaborate effectively to push the boundaries of scientific research and innovation, focusing on improving therapeutic options within the biopharmaceutical landscape.

Conclusion

Bradley Hayes exemplifies the spirit of innovation in the field of biotechnology. His patented work on antibody preparation processes not only advances laboratory techniques but also holds the potential to enhance the effectiveness of treatments in various medical applications. With his ongoing contributions at Seattle Genetics, Inc., Hayes continues to be a pivotal figure in the realm of biopharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…